Related references
Note: Only part of the references are listed.Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study
Luca Ceriani et al.
HEMATOLOGICAL ONCOLOGY (2017)
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma
Luca Ceriani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Report of the 6th International Workshop on PET in lymphoma
Cristina Nanni et al.
LEUKEMIA & LYMPHOMA (2017)
Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis
Georg Kuhnert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET)
Salvatore Annunziata et al.
ANNALS OF NUCLEAR MEDICINE (2016)
Clinical approach to diffuse large B cell lymphoma
Paolo F. Caimi et al.
BLOOD REVIEWS (2016)
FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
Josee M. Zijlstra et al.
HAEMATOLOGICA (2016)
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study
Pier Luigi Zinzani et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Peter Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
Josee M. Zijlstra et al.
HAEMATOLOGICA (2016)
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients
Tarec Christoffer El-Galaly et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
Craig S. Sauter et al.
BLOOD (2015)
Hodgkin lymphoma in children and adolescents: improving the therapeutic index
Kara M. Kelly
BLOOD (2015)
FDG PET/CT imaging as a biomarker in lymphoma
Michel Meignan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Christoph Mamot et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma
John Radford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET HAEMATOLOGY (2015)
PET/CT before autologous stem cell transplantation predicts
Marion Alcantara et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom
John J. Sunderland et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
When should FDG-PET be used in the modern management of lymphoma?
Sally Fiona Barrington et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Guidelines for the first line management of classical Hodgkin lymphoma
George A. Follows et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
Dirk Hasenclever et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET
Go Akamatsu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
Elske Quak et al.
HAEMATOLOGICA (2014)
Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma-Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Tim Illidge et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
Lena Specht et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
John M. M. Raemaekers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
Robert Carr et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Midtreatment 18F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center
Pek-Lan Khong et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma
Nathalie Nols et al.
LEUKEMIA & LYMPHOMA (2014)
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma
Cinzia Pellegrini et al.
ONCOLOGIST (2014)
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
Judith Trotman et al.
LANCET HAEMATOLOGY (2014)
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era
Deok-Hwan Yang et al.
ANNALS OF HEMATOLOGY (2013)
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
Silvia Fuertes et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
Emmanuel Itti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Are We Ready for Positron Emission Tomography/Computed Tomography-based Target Volume Definition in Lymphoma Radiation Therapy?
Kheng-Wei Yeoh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Prognostic Value of Interim and Posttherapy 18F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell Lymphomas
Ya-Jun Li et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
Alberto Biggi et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
The EuroNet Paediatric Hodgkin Network - Modern Imaging Data Management for Real Time Central Review in Multicentre Trials
L. Kurch et al.
KLINISCHE PADIATRIE (2013)
18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
Carla Casulo et al.
LEUKEMIA & LYMPHOMA (2013)
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
Patrizia Pregno et al.
BLOOD (2012)
Early interim F-18-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients
Pier Luigi Zinzani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High-Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
Jehan Dupuis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Anas Younes et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
Violaine Safar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Andreas Engert et al.
LANCET (2012)
Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future
Giampaolo Tomasi et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP
Changhoon Yoo et al.
ANNALS OF HEMATOLOGY (2011)
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma
S. F. Barrington et al.
ANNALS OF ONCOLOGY (2011)
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma
J. A. Barnes et al.
ANNALS OF ONCOLOGY (2011)
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
Ivana N. M. Micallef et al.
BLOOD (2011)
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
Rene -Olivier Casasnovas et al.
BLOOD (2011)
Midtreatment 18F-Fluorodeoxyglucose Positron-Emission Tomography in Aggressive Non-Hodgkin Lymphoma
Pier Luigi Zinzani et al.
CANCER (2011)
Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma
Deok-Hwan Yang et al.
EUROPEAN JOURNAL OF CANCER (2011)
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria
Pierre-Yves Le Roux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma
R. Kluge et al.
KLINISCHE PADIATRIE (2011)
Characterization of T-Cell Lymphomas by FDG PET/CT
John Feeney et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
Alison J. Moskowitz et al.
BLOOD (2010)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
Sally F. Barrington et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
F-18-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
Michal Weiler-Sagie et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background
Emmanuel Itti et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma
Juliano J. Cerci et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
CT and PET/CT Findings of T-Cell Lymphoma
Hansel J. Otero et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
Emmanuel Itti et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Qualification of PET Scanners for Use in Multicenter Cancer Clinical Trials: The American College of Radiology Imaging Network Experience
Joshua S. Scheuermann et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
PET/CT for Therapy Response Assessment in Lymphoma
Martin Hutchings et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Report on the First International Workshop on interim-PET scan in lymphoma
Michel Meignan et al.
LEUKEMIA & LYMPHOMA (2009)
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:: SUV-based assessment versus visual analysis
Chieh Lin et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
M Hutchings et al.
BLOOD (2006)
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
NG Mikhaeel et al.
ANNALS OF ONCOLOGY (2005)
Response assessment of aggressive non-Hodgkin's lymphoma by integrated international workshop criteria and fluorine-18-fluorodeoxyglucose positron emission tomography
ME Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
M Hutchings et al.
ANNALS OF ONCOLOGY (2005)
Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
K Spaepen et al.
ANNALS OF ONCOLOGY (2002)
Can positron emission tomography with [18F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
K Spaepen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma:: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
K Spaepen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
NG Mikhaeel et al.
LEUKEMIA & LYMPHOMA (2000)
Recovery correction for quantitation in emission tomography: a feasibility study
L Geworski et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
